These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

421 related articles for article (PubMed ID: 33034350)

  • 1. Approach to the Patient with MODY-Monogenic Diabetes.
    Broome DT; Pantalone KM; Kashyap SR; Philipson LH
    J Clin Endocrinol Metab; 2021 Jan; 106(1):237-250. PubMed ID: 33034350
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment switch from multiple daily insulin injections to sulphonylureas in an African young adult diagnosed with HNF1A MODY: a case report.
    Katte JC; Dehayem MY; Colclough K; Sobngwi E
    J Med Case Rep; 2024 Oct; 18(1):506. PubMed ID: 39420387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of hepatic nuclear factor 1A monogenic diabetes mellitus (HNF1A-MODY) impacts antihyperglycemic treatment.
    Schnedl WJ; Holasek SJ; Schenk M; Enko D; Mangge H
    Wien Klin Wochenschr; 2021 Mar; 133(5-6):241-244. PubMed ID: 33245425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A UK nationwide prospective study of treatment change in MODY: genetic subtype and clinical characteristics predict optimal glycaemic control after discontinuing insulin and metformin.
    Shepherd MH; Shields BM; Hudson M; Pearson ER; Hyde C; Ellard S; Hattersley AT; Patel KA;
    Diabetologia; 2018 Dec; 61(12):2520-2527. PubMed ID: 30229274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maturity onset diabetes of the young: Seek and you will find.
    Heuvel-Borsboom H; de Valk HW; Losekoot M; Westerink J
    Neth J Med; 2016 Jun; 74(5):193-200. PubMed ID: 27323672
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Should the negativity for islet cell autoantibodies be used in a prescreening for genetic testing in maturity-onset diabetes of the young? The case of autoimmunity-associated destruction of pancreatic β-cells in a family of HNF1A-MODY subjects.
    Urbanová J; Rypáčková B; Kučera P; Anděl M; Heneberg P
    Int Arch Allergy Immunol; 2013; 161(3):279-84. PubMed ID: 23548576
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MODY in Ukraine: genes, clinical phenotypes and treatment.
    Globa E; Zelinska N; Elblova L; Dusatkova P; Cinek O; Lebl J; Colclough K; Ellard S; Pruhova S
    J Pediatr Endocrinol Metab; 2017 Oct; 30(10):1095-1103. PubMed ID: 28862987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incretin hormones and maturity onset diabetes of the young--pathophysiological implications and anti-diabetic treatment potential.
    Østoft SH
    Dan Med J; 2015 Sep; 62(9):. PubMed ID: 26324089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of MODY Probability Calculator in probands of families with early-onset autosomal dominant diabetes from Poland.
    Hohendorff J; Zapala B; Ludwig-Slomczynska AH; Solecka I; Ucieklak D; Matejko B; Mrozinska S; Malecki MT; Szopa M
    Minerva Med; 2019 Dec; 110(6):499-506. PubMed ID: 31638358
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A New Tool to Identify Pediatric Patients with Atypical Diabetes Associated with Gene Polymorphisms.
    Welsch S; Harvengt A; Gallo P; Martin M; Beckers D; Mouraux T; Seret N; Lebrethon MC; Helaers R; Brouillard P; Vikkula M; Lysy PA
    Diabetes Metab J; 2024 Sep; 48(5):949-959. PubMed ID: 38523249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monogenic Defects of Beta Cell Function: From Clinical Suspicion to Genetic Diagnosis and Management of Rare Types of Diabetes.
    Serbis A; Kantza E; Siomou E; Galli-Tsinopoulou A; Kanaka-Gantenbein C; Tigas S
    Int J Mol Sci; 2024 Sep; 25(19):. PubMed ID: 39408828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Precision diabetes: Lessons learned from maturity-onset diabetes of the young (MODY).
    Tosur M; Philipson LH
    J Diabetes Investig; 2022 Sep; 13(9):1465-1471. PubMed ID: 35638342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of Islet Autoantibodies and Modestly Raised Glucose Values at Diabetes Diagnosis Should Lead to Testing for MODY: Lessons From a 5-Year Pediatric Swedish National Cohort Study.
    Carlsson A; Shepherd M; Ellard S; Weedon M; Lernmark Å; Forsander G; Colclough K; Brahimi Q; Valtonen-Andre C; Ivarsson SA; Elding Larsson H; Samuelsson U; Örtqvist E; Groop L; Ludvigsson J; Marcus C; Hattersley AT
    Diabetes Care; 2020 Jan; 43(1):82-89. PubMed ID: 31704690
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A single dose of dapagliflozin, an SGLT-2 inhibitor, induces higher glycosuria in GCK- and HNF1A-MODY than in type 2 diabetes mellitus.
    Hohendorff J; Szopa M; Skupien J; Kapusta M; Zapala B; Platek T; Mrozinska S; Parpan T; Glodzik W; Ludwig-Galezowska A; Kiec-Wilk B; Klupa T; Malecki MT
    Endocrine; 2017 Aug; 57(2):272-279. PubMed ID: 28593615
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patient perspectives on the diagnostic journey to a monogenic diabetes diagnosis: Barriers and facilitators.
    Guan Y; Maloney KA; Pollin TI
    J Genet Couns; 2020 Dec; 29(6):1106-1113. PubMed ID: 32162750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of maturity onset diabetes of the young (MODY) and challenges in the management of glucokinase-MODY.
    Bishay RH; Greenfield JR
    Med J Aust; 2016 Nov; 205(10):480-485. PubMed ID: 27852188
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of candidate gene variants of monogenic diabetes using targeted panel sequencing in early onset diabetes patients.
    Lee DH; Kwak SH; Park HS; Ku EJ; Jeon HJ; Oh TK
    BMJ Open Diabetes Res Care; 2021 Jun; 9(1):. PubMed ID: 34135026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monogenic diabetes mellitus in youth. The MODY syndromes.
    Winter WE; Nakamura M; House DV
    Endocrinol Metab Clin North Am; 1999 Dec; 28(4):765-85. PubMed ID: 10609119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic testing for misclassified monogenic diabetes in Māori and Pacific peoples in Aōtearoa New Zealand with early-onset type 2 diabetes.
    Toomata Z; Leask M; Krishnan M; Cadzow M; Dalbeth N; Stamp LK; de Zoysa J; Merriman T; Wilcox P; Dewes O; Murphy R
    Front Endocrinol (Lausanne); 2023; 14():1174699. PubMed ID: 37234800
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monogenic diabetes in New Zealand - An audit based revision of the monogenic diabetes genetic testing pathway in New Zealand.
    Harrington F; Greenslade M; Colclough K; Paul R; Jefferies C; Murphy R
    Front Endocrinol (Lausanne); 2023; 14():1116880. PubMed ID: 37033247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.